| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 19 | 2024 | 359 | 3.640 |
Why?
|
| Brain Injuries | 30 | 2024 | 801 | 1.880 |
Why?
|
| Glasgow Coma Scale | 19 | 2023 | 218 | 1.870 |
Why?
|
| Craniocerebral Trauma | 16 | 2023 | 155 | 1.700 |
Why?
|
| Cerebrovascular Circulation | 21 | 2017 | 515 | 1.660 |
Why?
|
| Intracranial Hypertension | 8 | 2016 | 125 | 1.320 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2017 | 89 | 1.200 |
Why?
|
| Decompressive Craniectomy | 2 | 2017 | 14 | 1.180 |
Why?
|
| Wounds, Gunshot | 6 | 2023 | 150 | 1.160 |
Why?
|
| Hematoma, Subdural, Acute | 2 | 2023 | 13 | 0.930 |
Why?
|
| Disability Evaluation | 3 | 2021 | 242 | 0.920 |
Why?
|
| Head Injuries, Closed | 4 | 2013 | 47 | 0.900 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2014 | 159 | 0.800 |
Why?
|
| Craniotomy | 5 | 2016 | 304 | 0.790 |
Why?
|
| Oxygen | 17 | 2015 | 800 | 0.640 |
Why?
|
| Xenon | 2 | 2017 | 22 | 0.630 |
Why?
|
| Occipital Bone | 2 | 2016 | 30 | 0.630 |
Why?
|
| Skull Neoplasms | 2 | 2016 | 68 | 0.620 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 220 | 0.620 |
Why?
|
| Intracranial Pressure | 17 | 2015 | 196 | 0.610 |
Why?
|
| Zygapophyseal Joint | 1 | 2018 | 14 | 0.610 |
Why?
|
| Withholding Treatment | 2 | 2021 | 155 | 0.590 |
Why?
|
| Hemoglobins | 3 | 2019 | 485 | 0.590 |
Why?
|
| Restraint, Physical | 1 | 2018 | 50 | 0.590 |
Why?
|
| Blood Transfusion | 4 | 2019 | 583 | 0.590 |
Why?
|
| Hypernatremia | 1 | 2017 | 28 | 0.580 |
Why?
|
| Life Support Care | 1 | 2017 | 52 | 0.580 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 120 | 0.570 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 7 | 0.570 |
Why?
|
| Injury Severity Score | 5 | 2019 | 248 | 0.570 |
Why?
|
| Spinal Fractures | 1 | 2018 | 140 | 0.540 |
Why?
|
| Morbidity | 1 | 2017 | 405 | 0.540 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2016 | 11 | 0.540 |
Why?
|
| Hydrocephalus | 3 | 2017 | 260 | 0.540 |
Why?
|
| Monitoring, Physiologic | 10 | 2012 | 536 | 0.530 |
Why?
|
| Hemangioma, Cavernous | 1 | 2016 | 32 | 0.530 |
Why?
|
| Adult | 68 | 2024 | 81889 | 0.520 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2015 | 25 | 0.510 |
Why?
|
| Spinal Puncture | 1 | 2015 | 62 | 0.510 |
Why?
|
| Glasgow Outcome Scale | 7 | 2021 | 49 | 0.510 |
Why?
|
| Aneurysm, False | 1 | 2016 | 143 | 0.500 |
Why?
|
| Meningioma | 4 | 2022 | 307 | 0.490 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2023 | 7791 | 0.470 |
Why?
|
| Recovery of Function | 6 | 2021 | 691 | 0.460 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2014 | 83 | 0.450 |
Why?
|
| Frontal Sinus | 1 | 2013 | 15 | 0.450 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 47 | 0.440 |
Why?
|
| Encephalocele | 1 | 2013 | 59 | 0.430 |
Why?
|
| Jugular Veins | 12 | 2001 | 113 | 0.420 |
Why?
|
| Male | 70 | 2024 | 128995 | 0.410 |
Why?
|
| Lateral Ventricles | 1 | 2012 | 26 | 0.410 |
Why?
|
| Skull Base Neoplasms | 2 | 2021 | 339 | 0.410 |
Why?
|
| Pineal Gland | 1 | 2012 | 49 | 0.400 |
Why?
|
| Germinoma | 1 | 2012 | 84 | 0.400 |
Why?
|
| Brain Abscess | 1 | 2012 | 69 | 0.390 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2011 | 4 | 0.390 |
Why?
|
| Superior Sagittal Sinus | 1 | 2011 | 4 | 0.390 |
Why?
|
| Hematoma | 5 | 1996 | 159 | 0.380 |
Why?
|
| Female | 64 | 2024 | 149187 | 0.380 |
Why?
|
| Meningeal Neoplasms | 3 | 2022 | 473 | 0.380 |
Why?
|
| Humans | 93 | 2024 | 271941 | 0.380 |
Why?
|
| Skull Fractures | 1 | 2011 | 49 | 0.370 |
Why?
|
| Oxygen Consumption | 9 | 2010 | 423 | 0.370 |
Why?
|
| Cerebral Hemorrhage | 4 | 1996 | 189 | 0.370 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2010 | 50 | 0.360 |
Why?
|
| Brain Neoplasms | 4 | 2022 | 4993 | 0.360 |
Why?
|
| Infratentorial Neoplasms | 1 | 2010 | 48 | 0.360 |
Why?
|
| Extracellular Space | 5 | 2010 | 148 | 0.350 |
Why?
|
| Middle Aged | 42 | 2021 | 90427 | 0.350 |
Why?
|
| Brain | 16 | 2022 | 4252 | 0.340 |
Why?
|
| Prospective Studies | 22 | 2024 | 13402 | 0.340 |
Why?
|
| Young Adult | 21 | 2023 | 22127 | 0.340 |
Why?
|
| Pituitary Neoplasms | 1 | 2011 | 218 | 0.320 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 634 | 0.310 |
Why?
|
| Erythropoietin | 4 | 2019 | 219 | 0.300 |
Why?
|
| Brain Ischemia | 4 | 1999 | 316 | 0.300 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 343 | 0.290 |
Why?
|
| Spectrophotometry, Infrared | 3 | 1995 | 38 | 0.270 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 417 | 0.260 |
Why?
|
| Oximetry | 5 | 1998 | 189 | 0.260 |
Why?
|
| Microdialysis | 10 | 2010 | 70 | 0.260 |
Why?
|
| Adolescent | 23 | 2019 | 32687 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2017 | 5690 | 0.250 |
Why?
|
| Brain Edema | 2 | 2010 | 96 | 0.250 |
Why?
|
| Transducers, Pressure | 2 | 1995 | 15 | 0.240 |
Why?
|
| Monitoring, Intraoperative | 3 | 1997 | 265 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 7929 | 0.230 |
Why?
|
| Brain Concussion | 3 | 2021 | 225 | 0.230 |
Why?
|
| Glutamic Acid | 2 | 2010 | 335 | 0.230 |
Why?
|
| Firearms | 1 | 2023 | 44 | 0.220 |
Why?
|
| Erythrocyte Transfusion | 2 | 2015 | 211 | 0.210 |
Why?
|
| Treatment Outcome | 13 | 2021 | 33874 | 0.200 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2021 | 12 | 0.200 |
Why?
|
| Aged | 20 | 2021 | 73494 | 0.200 |
Why?
|
| Critical Care | 5 | 2016 | 810 | 0.190 |
Why?
|
| Retrospective Studies | 14 | 2024 | 39800 | 0.190 |
Why?
|
| Age Factors | 4 | 2017 | 5521 | 0.190 |
Why?
|
| Neurosurgery | 1 | 2022 | 117 | 0.190 |
Why?
|
| Skull | 1 | 2023 | 252 | 0.190 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 54 | 0.190 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2021 | 48 | 0.180 |
Why?
|
| Anesthesia | 1 | 2024 | 306 | 0.180 |
Why?
|
| Head Injuries, Penetrating | 1 | 2019 | 6 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 10365 | 0.170 |
Why?
|
| Prognosis | 12 | 2021 | 22550 | 0.170 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 31 | 0.170 |
Why?
|
| Aspartic Acid | 1 | 2000 | 136 | 0.170 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 2053 | 0.170 |
Why?
|
| Lactic Acid | 6 | 2022 | 312 | 0.160 |
Why?
|
| Cognition | 2 | 2023 | 982 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 2286 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 4399 | 0.160 |
Why?
|
| Astrocytes | 1 | 2022 | 406 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2010 | 131 | 0.150 |
Why?
|
| Braces | 1 | 2018 | 13 | 0.150 |
Why?
|
| Radiography | 2 | 2014 | 1993 | 0.150 |
Why?
|
| Survival Rate | 4 | 2017 | 12533 | 0.150 |
Why?
|
| Erdheim-Chester Disease | 1 | 2017 | 55 | 0.150 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 15269 | 0.140 |
Why?
|
| Hemodynamics | 4 | 2015 | 973 | 0.140 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 177 | 0.140 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2017 | 28 | 0.140 |
Why?
|
| Occipital Lobe | 1 | 2016 | 47 | 0.140 |
Why?
|
| Surgical Flaps | 1 | 2023 | 882 | 0.140 |
Why?
|
| Aftercare | 1 | 2018 | 255 | 0.140 |
Why?
|
| Patient Care | 1 | 2017 | 151 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 329 | 0.140 |
Why?
|
| Seizures | 2 | 2013 | 1032 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 90 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 224 | 0.130 |
Why?
|
| Risk Factors | 6 | 2021 | 18047 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 852 | 0.130 |
Why?
|
| Ventriculostomy | 1 | 1995 | 42 | 0.130 |
Why?
|
| Cytokines | 2 | 2019 | 2841 | 0.130 |
Why?
|
| Hypoxia, Brain | 3 | 2001 | 36 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 219 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 410 | 0.120 |
Why?
|
| Adie Syndrome | 1 | 2014 | 4 | 0.120 |
Why?
|
| Cauda Equina | 1 | 2014 | 13 | 0.120 |
Why?
|
| Laughter | 1 | 1994 | 10 | 0.120 |
Why?
|
| Laminectomy | 1 | 2014 | 52 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 5118 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 4998 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2017 | 731 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 429 | 0.110 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 12 | 0.110 |
Why?
|
| Trauma Centers | 4 | 2021 | 187 | 0.110 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2023 | 9494 | 0.110 |
Why?
|
| Blood Gas Analysis | 4 | 2008 | 106 | 0.110 |
Why?
|
| Injections, Spinal | 1 | 2013 | 275 | 0.110 |
Why?
|
| Meningitis, Bacterial | 1 | 2013 | 100 | 0.100 |
Why?
|
| Lipoma | 1 | 1992 | 94 | 0.100 |
Why?
|
| Disease Management | 1 | 2018 | 1111 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 661 | 0.100 |
Why?
|
| Motorcycles | 1 | 2011 | 8 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2019 | 1730 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 596 | 0.100 |
Why?
|
| Hypophysectomy | 1 | 2011 | 28 | 0.100 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 606 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1437 | 0.090 |
Why?
|
| Neurophysins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 473 | 0.090 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 13 | 0.090 |
Why?
|
| Time Factors | 6 | 2021 | 13130 | 0.090 |
Why?
|
| Hyperventilation | 1 | 2010 | 21 | 0.090 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 118 | 0.090 |
Why?
|
| Vasopressins | 1 | 2010 | 64 | 0.090 |
Why?
|
| Whipple Disease | 1 | 2010 | 7 | 0.090 |
Why?
|
| Consciousness | 1 | 2010 | 55 | 0.090 |
Why?
|
| Cerebrum | 1 | 2010 | 41 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4352 | 0.090 |
Why?
|
| Central Nervous System Infections | 1 | 2010 | 21 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 3469 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 278 | 0.090 |
Why?
|
| Headache | 1 | 2011 | 175 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 100 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 3176 | 0.090 |
Why?
|
| Embolism | 1 | 2009 | 66 | 0.080 |
Why?
|
| Pupil | 1 | 2009 | 63 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2010 | 252 | 0.080 |
Why?
|
| Neurocysticercosis | 1 | 2009 | 26 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 31060 | 0.080 |
Why?
|
| Persistent Vegetative State | 2 | 2021 | 11 | 0.080 |
Why?
|
| Biomarkers | 2 | 2019 | 5114 | 0.080 |
Why?
|
| Disease Progression | 2 | 2019 | 6910 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2012 | 507 | 0.080 |
Why?
|
| Pentobarbital | 2 | 1999 | 28 | 0.080 |
Why?
|
| Anemia | 1 | 2014 | 730 | 0.080 |
Why?
|
| Incidence | 5 | 2021 | 5861 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 3 | 1999 | 220 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 12012 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2009 | 291 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2009 | 221 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2021 | 6883 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 370 | 0.070 |
Why?
|
| Arthrography | 1 | 2007 | 9 | 0.070 |
Why?
|
| Spondylolisthesis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2017 | 9325 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 510 | 0.070 |
Why?
|
| Neurologic Examination | 3 | 2014 | 267 | 0.070 |
Why?
|
| Quality of Life | 1 | 2021 | 4749 | 0.070 |
Why?
|
| Joint Instability | 1 | 2007 | 78 | 0.070 |
Why?
|
| Hyperoxia | 1 | 2008 | 138 | 0.060 |
Why?
|
| Body Temperature | 2 | 1998 | 165 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 2534 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 1999 | 636 | 0.060 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 1995 | 11 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2009 | 380 | 0.060 |
Why?
|
| Hematoma, Subdural | 2 | 1995 | 30 | 0.060 |
Why?
|
| United States | 4 | 2023 | 16053 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 4891 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 379 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2958 | 0.050 |
Why?
|
| Coma | 3 | 1999 | 67 | 0.050 |
Why?
|
| Palliative Care | 1 | 2014 | 2159 | 0.050 |
Why?
|
| Neuroprotection | 1 | 2022 | 21 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 92 | 0.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2019 | 1242 | 0.050 |
Why?
|
| Smoking | 1 | 2011 | 2538 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 2 | 1999 | 66 | 0.050 |
Why?
|
| Xanthine | 1 | 2001 | 14 | 0.050 |
Why?
|
| Workload | 1 | 2022 | 199 | 0.050 |
Why?
|
| Carbon Dioxide | 3 | 1997 | 331 | 0.050 |
Why?
|
| Brain Death | 2 | 1998 | 59 | 0.050 |
Why?
|
| Excitatory Amino Acids | 2 | 1998 | 11 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 2001 | 169 | 0.040 |
Why?
|
| Child | 4 | 2014 | 30499 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1435 | 0.040 |
Why?
|
| Cholesterol | 1 | 2023 | 681 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2021 | 502 | 0.040 |
Why?
|
| Anaerobic Threshold | 1 | 1998 | 12 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 493 | 0.040 |
Why?
|
| Adenosine | 1 | 2001 | 300 | 0.040 |
Why?
|
| Magnesium | 1 | 1999 | 172 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 696 | 0.040 |
Why?
|
| Pamphlets | 1 | 2018 | 33 | 0.040 |
Why?
|
| Hypotension | 2 | 1998 | 237 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 559 | 0.040 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2017 | 9 | 0.040 |
Why?
|
| Rewarming | 1 | 1997 | 14 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1997 | 394 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1996 | 101 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 1999 | 159 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 147 | 0.040 |
Why?
|
| Potassium | 1 | 1999 | 349 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 796 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 1263 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 5755 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 1999 | 743 | 0.040 |
Why?
|
| Probability | 1 | 2019 | 887 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 1175 | 0.040 |
Why?
|
| Partial Pressure | 2 | 2012 | 34 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 464 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 123 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 1997 | 124 | 0.030 |
Why?
|
| Glucose | 2 | 1999 | 1245 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 699 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2001 | 1286 | 0.030 |
Why?
|
| Rabbits | 2 | 1997 | 1077 | 0.030 |
Why?
|
| Pseudotumor Cerebri | 1 | 1996 | 62 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 653 | 0.030 |
Why?
|
| Miniaturization | 1 | 1995 | 49 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1999 | 2337 | 0.030 |
Why?
|
| Arteries | 1 | 1996 | 294 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 306 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1995 | 85 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 2679 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 531 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 259 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 2202 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1994 | 198 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 482 | 0.030 |
Why?
|
| Catheterization | 1 | 1996 | 425 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1995 | 177 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 2150 | 0.030 |
Why?
|
| Calibration | 1 | 1994 | 346 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 153 | 0.030 |
Why?
|
| Brain Stem | 1 | 1994 | 185 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 1436 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1555 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1594 | 0.030 |
Why?
|
| Amino Acids | 1 | 1996 | 788 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1995 | 383 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 1992 | 148 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1993 | 334 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 1155 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 2439 | 0.030 |
Why?
|
| Chordoma | 1 | 1994 | 170 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 1066 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 5433 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 6210 | 0.020 |
Why?
|
| Prevalence | 1 | 2019 | 3426 | 0.020 |
Why?
|
| Neurons | 1 | 2022 | 2461 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 5195 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2012 | 335 | 0.020 |
Why?
|
| Vacuum | 1 | 2010 | 42 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1995 | 463 | 0.020 |
Why?
|
| Syringes | 1 | 2010 | 40 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 729 | 0.020 |
Why?
|
| Equipment Design | 1 | 1993 | 1207 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2010 | 171 | 0.020 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2009 | 30 | 0.020 |
Why?
|
| Optical Fibers | 1 | 2009 | 39 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 160 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2001 | 1603 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5929 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 6236 | 0.020 |
Why?
|
| Antiparasitic Agents | 1 | 2009 | 36 | 0.020 |
Why?
|
| Infant | 2 | 1995 | 13936 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 1248 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2001 | 591 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1995 | 17006 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5187 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 1100 | 0.020 |
Why?
|
| Glycolysis | 2 | 2001 | 534 | 0.020 |
Why?
|
| Recurrence | 1 | 1995 | 4887 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 761 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 481 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 460 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2007 | 150 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 959 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 447 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 720 | 0.010 |
Why?
|
| Catheterization, Central Venous | 2 | 1999 | 366 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 3646 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 8100 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 1943 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 4266 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 2514 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2011 | 2157 | 0.010 |
Why?
|
| Nervous System | 1 | 2001 | 183 | 0.010 |
Why?
|
| Diuretics, Osmotic | 1 | 1999 | 6 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 404 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 285 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 1999 | 98 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1999 | 104 | 0.010 |
Why?
|
| Cations | 1 | 1998 | 60 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 1588 | 0.010 |
Why?
|
| Anesthesia, Endotracheal | 1 | 1997 | 6 | 0.010 |
Why?
|
| Oxygenators, Membrane | 1 | 1997 | 11 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1997 | 18 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 995 | 0.010 |
Why?
|
| Drainage | 1 | 1999 | 448 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1997 | 173 | 0.010 |
Why?
|
| Hypoxia | 1 | 1999 | 477 | 0.010 |
Why?
|
| Critical Illness | 1 | 2001 | 741 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1995 | 66 | 0.010 |
Why?
|
| Animals | 3 | 1997 | 62823 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1995 | 91 | 0.010 |
Why?
|
| Vena Cava, Superior | 1 | 1995 | 78 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1995 | 134 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 622 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 2366 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 1742 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1995 | 543 | 0.010 |
Why?
|
| Swine | 1 | 1995 | 1610 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 1999 | 1458 | 0.010 |
Why?
|